Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma
Conditions: Adult Anaplastic Astrocytoma; Adult Anaplastic Ependymoma; Adult Anaplastic Oligodendroglioma; Adult Brain Stem Glioma; Adult Ependymoblastoma; Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Adult Mixed Glioma; Adult Pineal Gland Astrocytoma; Recurrent Adult Brain TumorInterventions: Biological: IL13Rα2-specific, hinge-optimized, 41BB-costimulatory CAR/truncated CD19-expressing T lymphocytes; Other: laboratory biomarker analysis; Other: quality-of-life assessmentSponsors: City of Hope Medical Center; National Cancer Institute (NCI)Not yet recruiting - verified January 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Astrocytoma | Brain Stem Giloma | Brain Tumor | Cancer & Oncology | Ependymoma | Genetics | Glioma | Research